GWM
ITDE icon

Geneos Wealth Management’s iShares LifePath Target Date 2045 ETF ITDE Stock Holding History

Geneos Wealth Management’s Portfolio ITDE Stock Details ITDE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1K Hold
1,250
– – ﹤0.01% 1462
2026
Q1 		$44.8K Hold
1,250
– – ﹤0.01% 1472
2025
Q4 		$45.3K Hold
1,250
– – ﹤0.01% 1433
2025
Q3 		$44.9K Hold
1,250
– – ﹤0.01% 1426
2025
Q2 		$42K Buy
1,250
+150
+14% +$4.72K ﹤0.01% 1668
2025
Q1 		$33.8K Buy
+1,100
New +$34.6K ﹤0.01% 1685

Other funds holding ITDE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Geneos Wealth Management's ITDE Position: Q2 2026 in Review

Geneos Wealth Management held its iShares LifePath Target Date 2045 ETF (ITDE) position steady in Q2 2026 at 1,250 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Geneos Wealth Management first reported a position in ITDE in Q1 2025 and has held it in 6 quarters since. 6 funds tracked by Wall St. Rank hold ITDE as of Q2 2026.

  • Geneos Wealth Management held 1,250 shares of iShares LifePath Target Date 2045 ETF worth $50.1K as of Q2 2026.
  • Geneos Wealth Management left its iShares LifePath Target Date 2045 ETF share count unchanged in Q2 2026.
  • iShares LifePath Target Date 2045 ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1462 holding.
  • Geneos Wealth Management first reported a position in iShares LifePath Target Date 2045 ETF in Q1 2025 and has held it in 6 quarters since.
  • 6 funds tracked by Wall St. Rank held iShares LifePath Target Date 2045 ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.